The onset of the disease likely starts decades before the first symptoms of cognitive decline appear, when changes in amyloid-beta (Aβ) or tau in the cerebrospinal fluid (CSF) as well as in positron emission tomography (PET) measurements become detectable (5). The gene discussed is MAPT; the disease is Mental deterioration.